期刊文献+

替加环素与亚胺培南西司他丁治疗医院获得性肺炎的临床对比观察 被引量:3

下载PDF
导出
摘要 目的对比分析替加环素与亚胺培南西司他丁治疗医院获得性肺炎的临床疗效。方法 200例医院获得性肺炎患者,随机分为观察组和对照组,各100例。观察组患者予以替加环素治疗,对照组患者予以亚胺培南西司他丁治疗,对比两组患者的临床疗效及细菌清除率。结果观察组患者无效16例,显效28例,痊愈56例,总有效率为84.00%(84/100);对照组患者无效34例,显效36例,痊愈30例,总有效率为66.00%(66/100)。观察组患者总有效率明显高于对照组,差异有统计学意义(P<0.05)。观察组患者细菌清除68例,细菌清除率为68.00%(68/100);对照组患者细菌清除40例,细菌清除率为40.00%(40/100)。观察组患者细菌清除率明显高于对照组,差异有统计学意义(P<0.05)。结论相较于亚胺培南西司他丁,采用替加环素治疗医院获得性肺炎患者临床疗效更佳。
作者 赵国南
出处 《中国现代药物应用》 2019年第6期100-101,共2页 Chinese Journal of Modern Drug Application
  • 相关文献

参考文献7

二级参考文献53

  • 1Takashi Akima,Masaya Tamano,Hidetsugu Yamagishi,Keiichi Kubota,Takahiro Fujimori,Hideyuki Hiraishi.Surgical treatment of HCC in a patient with lamivudine-resistant hepatitis B cirrhosis with adefovir dipivoxil[J].World Journal of Hepatology,2010,2(8):318-321. 被引量:11
  • 2王宏敏,杜文民,徐建龙,王晓瑜.抗感染药物的不良反应报告248例分析[J].中国新药与临床杂志,2004,23(9):646-648. 被引量:8
  • 3SUNENSHINE RH, WRIGHT MO, MARAGAKIS LL, et ol. Muhidrug- resistant Acinetobacter infection mortality rate and length of hospitalization [J]. Emerg Infect Dis, 2007, 13 ( 1 ) : 97-103. 被引量:1
  • 4WAREHAM DW, BEAN DC, KHANNA P, et al. Bloodstream infection due to Acinetobacter spp: epidemiology, risk factors and impact of multi-drug resistance[J]. Eur J Clin Microbiol Infect Dis, 2008, 27(7): 607-612. 被引量:1
  • 5FALAGAS ME, RAFAILIDIS PI. Attributable mortality of Acinetobacter baumannii: no longer a controversial issue[J]. Crit Care, 2007, 11(3): 134. 被引量:1
  • 6FALAGAS ME, KASIAKOU SK, RAFAILIDIS PI, et ol. Comparison of mortality of patients with Acinetobacter baurnaonii bacteraemia receiving appropriate and inappropriate empirical therapy[J]. J Antimicrob Chemother, 2006, 57(6): 1251-1254. 被引量:1
  • 7FALAGAS ME, BLIZIOTIS IA, SIEMPOS II. Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies[J]. Crit Care, 2006, 10(2) : R48. 被引量:1
  • 8TURNER PJ. MYSTIC Europe 2007: activity of meropenem and other broad-spectrum agents against nosocomial isolates[J]. Diagn Microbiol Infect Dis, 2009, 63(2): 217-222. 被引量:1
  • 9RHOMBERG PR, JONES RN. Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999- 2008)[J]. Diagn Microbiol Infect Dis, 2009, 65(4): 414-426. 被引量:1
  • 10DIZBAY M, ALTUNCEKIC A, SEZER BE, et al. Colistin and tigecycline susceptibility among multidrug-resistant A cinetobacter baumannii isolated from ventilator-associated pneumonia[J]. Int J Antimicrob Agents, 2008, 32(1): 29-32. 被引量:1

共引文献76

同被引文献35

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部